Advances in Radiation Oncology (Mar 2024)

Radiation Therapy Skin Marking with Lancets Versus Electric Marking Pen (COMFORTATTOO)—6 Months Results on Cosmesis, Fading, and Patients’ Satisfaction From a Randomized, Double-Blind Trial

  • André M. Pires, MD,
  • Luísa Carvalho, MD,
  • Ana C. Santos, BsC,
  • Ana M. Vilaça, BsC,
  • Ana R. Coelho, MsC,
  • Celeste Oliveira, MsC,
  • Céline Costa, MsC,
  • Flávia Fernandes, MD,
  • Liliana Moreira, BsC,
  • João Lima, MD,
  • Rafaela Vieira, BsC,
  • Maria J. Ferraz, BsC,
  • Marta Silva, BsC,
  • Pedro Silva, MsC,
  • Rafael Matias, MD,
  • Sara Zorro, MD,
  • Susana Costa, PhD,
  • Susana Sarandão, MD,
  • Ana F. Barros, BsC

Journal volume & issue
Vol. 9, no. 3
p. 101404

Abstract

Read online

Purpose: Most of radiation oncology centers rely on set-up skin markings for patient setup during treatment delivery. Permanent dark-ink tattooing is the most popular marking method. COMFORTATTOO is a unicentric, randomized trial testing 2 permanent methods: lancets against an electric marking pen (Comfort Marker 2.0, CM). One substudy was undertaken to test if using the CM translates into a cosmesis, fading, or satisfaction benefit compared with the lancets. Methods and Materials: Patients aged 18 years or older referred to our department to receive RT were recruited. They were randomly assigned, in a 1:1 ratio, to receive set-up markings using lancets or CM. This substudy aimed to recruit all the living participants included in the main study. The primary endpoints were tattoos cosmesis, tattoos fading, and patients’ satisfaction 6 months after finishing the RT. Cosmetic and fading assessments were scored on a 5-point ascending scale and patients’ satisfaction on a 10-point ascending scale. The trial is registered at ClinicalTrials.gov (number NCT05371795). Results: Between April and September 2022, 92 patients were enrolled (45 assigned to lancets and 47 to CM) and assessed for the outcomes. Patients receiving CM had significantly better cosmetic markings, with a median score of 4.4 (vs 3.7 for lancets, P<.001). On the fading assessment, the CM was associated with lower scores compared with the lancets (median score of 1.3 and 3.3, respectively; P<.001). No differences in patients’ satisfaction were observed with either method (median score of 10 for both arms, P=.952). Conclusions: Our substudy results demonstrated that, 6 months after the end of RT, the CM produces better cosmetic markings with less fading compared with the lancets. These differences didn't translate into patients’ satisfaction superiority toward any method.